Background: Type 1 diabetes (T1D) is a multifactorial autoimmune disease, involving strong genetic components with familial predisposition. Human leukocyte antigen-G (HLA-G) is a non-classical HLA-class I molecule having several immunomodulatory functions. Polymorphisms in are associated with several autoimmune diseases including T1D. This study aims to evaluate the association of 14bp Ins/Del and +3142 C/G polymorphisms with T1D among the South Indian population.
Methods: The study was performed in a cohort of 123 T1D patients along with their 51 siblings and 126 parents. The association and linkage of 14bp Ins/Del and +3142 C/G polymorphisms with T1D were analysed, and transmission disequilibrium test (TDT) was performed.
Results: Significantly increased frequencies of 14bp Del/Del genotype (OR = 2.16, p = 0.0302) and Del allele (OR = 1.71, p = 0.0398) were observed in female patients compared to parents. Higher frequencies of DelDel/GG combined genotype (OR = 4.45, p = 0.0049) and Del/G haplotype (OR = 2.91, p = 0.0277) were observed in female patients compared to parents. TDT also revealed over-transmission of Del/G haplotype (25T vs 7UT; = 0.0015) and a strong linkage disequilibrium between the studied polymorphisms.
Conclusion: This familial study shows the association of 3'UTR 14bp Ins/Del polymorphism with the risk of T1D among the South Indian population, especially in females.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424110 | PMC |
http://dx.doi.org/10.4103/ijem.ijem_7_22 | DOI Listing |
Biochem Genet
November 2024
Department of Zoology, College of Science, King Saud University, Riyadh, Saudi Arabia.
Am J Reprod Immunol
December 2023
Gynecology Department, Hospital of Chengdu University of TCM, Chengdu, China.
Problem: The immune system plays an essential role in embryonic implantation and pregnancy, but the molecular details remain controversial. In the past four decades, human leukocyte antigen (HLA)-G and -F have garnered significant attention.
Method Of Study: MEDLINE, EMBASE, Web of Science, and the Cochrane Trials Registry were searched from their inception dates until December 2022.
Curr Issues Mol Biol
August 2023
Centro Universitario de Ciencias de la Salud, Laboratorio de Inmunología, Departamento de Fisiología, Universidad de Guadalajara, Sierra Mojada #950, Guadalajara 44340, Mexico.
HLA-G is a physiology and pathologic immunomodulator detrimentally related to cancer. Its gene is heavily transcriptionally and post-transcriptionally regulated by variants located in regulator regions like 3'UTR, being the most studied Ins/Del of 14-bp (rs66554220), which is known to influence the effects of endogen cell factors; nevertheless, the reports are discrepant and controversial. Herein, the relationship of the 14-bp Ins/Del variant (rs66554220) with breast cancer (BC) and its clinical characteristics were analyzed in 182 women with non-familial BC and 221 disease-free women as a reference group.
View Article and Find Full Text PDFIndian J Endocrinol Metab
June 2023
Department of Immunology, School of Biological Sciences, Madurai Kamaraj University, Madurai, Tamil Nadu, India.
Background: Type 1 diabetes (T1D) is a multifactorial autoimmune disease, involving strong genetic components with familial predisposition. Human leukocyte antigen-G (HLA-G) is a non-classical HLA-class I molecule having several immunomodulatory functions. Polymorphisms in are associated with several autoimmune diseases including T1D.
View Article and Find Full Text PDFFront Immunol
December 2022
Department of Reproductive Medicine Center, Foshan Maternal and Child Health Care Hospital, Southern Medical University, Guangzhou, China.
Introduction: HLA-G plays a central role in immune tolerance at the maternal-fetal interface. The HLA-G gene is characterized by low allelic polymorphism and restricted tissue expression compared with classical HLA genes. HLA-G polymorphism is associated with HLA-G expression and linked to pregnancy complications.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!